Hairex

Quick links to important sections

Hairex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hairex

Property Description
Active ingredient Minoxidil
Form Topical Solution or Topical Foam
Pharmacological class Peripheral Vasodilator, Potassium Channel Opener
Common use Hair growth stimulation for androgenetic alopecia
Origin Synthetic

Defining Hairex: Type, Composition, and Origin

Hairex is a medicinal preparation whose sole active ingredient is Minoxidil, a synthetic small molecule that is classified as a peripheral vasodilator. Its unique mechanism relies on its function as a potassium channel opener at the cellular level, a property that is clinically recognized by pharmacological studies.

Minoxidil was originally developed and employed systemically as a potent antihypertensive agent for severe high blood pressure. This history underscores its significant physiological impact. For the purpose of hair regrowth, Hairex utilizes this compound as a single-ingredient product, which specifically targets the scalp area to manage hair thinning in adult men and women.

Pharmaceutical Form and General Therapeutic Purpose

The route of administration for Hairex is strictly topical, confining the application to the scalp. The medication is reliably offered in two principal dosage forms: a liquid topical solution and a lighter, often preferred, topical foam.

The general therapeutic purpose of Hairex is to support the stabilization of hair loss and stimulate the regrowth of hair in individuals experiencing hereditary thinning, clinically termed androgenetic alopecia. By promoting increased microcirculation and encouraging hair follicles to remain in their active growth phase, the medication provides a pharmaceutical means to counteract this common type of hair loss.

Regulatory References

  1. Minoxidil - NCBI Bookshelf
  2. Minoxidil - DailyMed - NIH

What side effects are possible with Hairex?

Possible side effects and safety information

The safety profile of Hairex (topical minoxidil) is formally documented in regulatory texts, categorizing adverse reactions by frequency and physiological system. This information helps structure the understanding of possible effects linked to the medicine.

Adverse effects are grouped into standard frequency categories:

  • Very Common: Effects reported in 1 in 10 individuals or more, most notably headache.
  • Common: Effects reported in 1 to 10 in 100 individuals, which include hypertrichosis (unwanted non-scalp hair growth), itching (pruritus), skin inflammation (dermatitis), hypertension, peripheral oedema (swelling), chest pain, and weight increase.
  • Uncommon/Rare: Less frequent effects such as dizziness, nausea, palpitations, and changes in hair texture.

Reactions are classified by the affected System-Organ Class, primarily including Skin and Subcutaneous Tissue Disorders (local reactions, hypertrichosis), Nervous System Disorders, and Cardiac/Vascular Disorders.

Serious adverse reactions are officially documented, typically those related to systemic absorption. These can include sudden, unexplained weight gain, chest pain, rapid heartbeat (tachycardia), or signs of a severe allergic reaction like Angioedema (swelling of the face, tongue, or throat).

Regulatory documents outline specific safety considerations for certain groups and contexts. Use is not recommended for individuals under 18 years of age. For women, the higher 5% concentration is generally contraindicated due to the increased risk of hypertrichosis. Furthermore, the risk of systemic effects, including cardiovascular reactions, may increase if the medicine is applied to a red, inflamed, or irritated scalp. Temporary hair shedding may be observed during the initial phase of treatment.

Overdose and Emergency Response

The official regulatory profile for Hairex overdose is based on the risk of excessive systemic absorption of Minoxidil, which acts as a potent peripheral vasodilator. Overdose manifestations therefore reflect significant cardiovascular effects and fluid disturbances. Information regarding overdose presentation and mandated actions is derived strictly from government regulatory documentation.


Documented Overdose Manifestations

Classification Clinical Signs and Symptoms (as listed in regulatory labels)
Cardiovascular/Neurological Hypotension (low blood pressure), Tachycardia (rapid heartbeat), Dizziness, Flushing, Headache, Lethargy, Syncope (fainting).
Fluid/Metabolic Edema (swelling of face, hands, or feet), Unexplained rapid weight gain, Nausea, Vomiting.

Officially Required Emergency Actions

Regulatory labeling requires immediate action when systemic toxicity is suspected. Individuals must seek immediate medical attention or contact a Poison Control Center following accidental oral ingestion or if signs of systemic absorption occur. Specifically, urgent medical help must be sought if any symptoms appear, including chest pain (Angina Pectoris), rapid heartbeat, dizziness, fainting, or sudden, severe swelling.

Overdose management is symptomatic and supportive treatment. No specific antidote is known; procedures described in official documents include intravenous volume replacement with normal saline for hypotension and diuretic therapy to manage severe fluid retention. Intensive monitoring may be required for sustained cardiovascular instability.

Therapeutic Uses of Hairex

What Hairex Treats: Main Uses and Benefits

Hairex is generally used for managing the chronic and progressive symptoms of hereditary pattern hair loss (androgenic alopecia) in both men and women.

The treatment is applied across domains where additional symptomatic support is needed to address the chronic and gradual symptoms of pattern thinning and balding on the scalp. Hairex is commonly used for its ability to help stabilize existing hair loss and stimulate the growth of new, visible hairs. This action assists with managing the visible progression of the condition and may assist in the appearance of visibly denser hair. The supportive relief may help patients cope more steadily with symptom fluctuations.

The medication is applied to address symptoms related to gradual hair thinning and balding at the crown of the head.

Quick Fact: Relief for Gradual Thinning The treatment is relevant in conditions characterized by periods of heightened symptoms (i.e., visible loss) that interfere with daily comfort.

Eligibility and Restrictions for Use

Hairex (Topical Minoxidil) is officially approved for use in adults between the ages of 18 and 65 years who are experiencing hereditary pattern hair loss (androgenetic alopecia). Eligibility is defined by strict regulatory parameters concerning age, underlying health, and the condition of the application site.

Contraindications and Restrictions

Use is formally contraindicated for individuals with a known hypersensitivity to minoxidil or any of its inactive components. Regulatory labeling prohibits application to a red, inflamed, infected, or damaged scalp. The medicine must not be used for hair loss that is sudden, patchy, or of unknown origin, as these conditions fall outside the established use criteria. Some regulatory guidance also contraindicates use in patients with pre-existing hypertension or cardiovascular disease.

Age and Reproductive Status:

  • Use is not recommended for populations outside the 18–65 age range, as safety and effectiveness have not been established in children, adolescents, or adults over 65 years.
  • The product is not recommended for women who are pregnant or breastfeeding, as minoxidil may be secreted into human milk or potentially cause harm during pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation outlines specific drug and product interactions for Hairex (topical minoxidil), primarily focusing on factors that alter absorption or systemic effect potentiation.

Documented Interaction Patterns

Co-administration of Hairex with other topical medicinal products on the same area of the scalp is restricted by official labeling. Certain topical agents, such as Tretinoin and Dithranol, are documented to increase the percutaneous absorption of minoxidil, leading to enhanced systemic exposure. Conversely, the co-administration of Low-dose Aspirin is officially associated with diminishing the medicine's effectiveness due to its inhibitory effect on the sulfotransferase enzyme required for minoxidil's activation.

Interaction cautions also extend to systemic agents. A theoretical risk of potentiating orthostatic hypotension exists if systemically absorbed minoxidil is combined with Peripheral Vasodilators or Guanethidine. Concurrently using systemic Cyclosporine may also exacerbate the adverse effect of hypertrichosis.

Restrictions and Conditions

Timing-based rules mandate that Hairex must not be used 24 hours before and after cosmetic procedures like hair coloring or permanents. Additionally, the presence of scalp lesions or irritation is cited as a condition that increases the risk of systemic effects due to greater minoxidil absorption.

Mechanism of Action

Enzymatic Inhibition and Androgen Receptor Blockade

Hairex acts as an inhibitor of the Type II 5-alpha reductase enzyme, which reduces the conversion of testosterone to dihydrotestosterone (DHT) in targeted peripheral tissues, notably the scalp. This dual-action mechanism also involves competitive antagonism at the intracellular androgen receptors (AR), physically blocking residual DHT from binding and preventing activation of the receptor signaling pathway.


Mechanistic Cascade and Physiological Modulation

The reduction in DHT-mediated signaling initiates a cascade that modulates the hair follicle growth cycle. By reducing this suppressive hormonal input, Hairex counteracts follicular miniaturization, which is the progressive shrinking of hair follicles. This modulation is characterized by the elongation of the anagen (growth) phase and a shift toward the morphology of terminal hairs. The drug's activity adjusts the function of peripheral, androgen-dependent systems, contributing to the establishment of a regulated physiological state in affected follicles.

Dosage and Administration Information

Hairex is administered exclusively via topical application directly to the scalp, utilizing either a Topical Solution (2% or 5%) or a Topical Foam (5%). This administration method defines the use of the medicine as a localized therapy focused solely on the scalp area.

The standard labeled regimen specifies applying a precise amount twice daily, typically in the morning and evening. For the solution, this amount is 1 mL per application, while for the foam, it is half a capful. The total daily application must not exceed 2 mL or 2 grams, as exceeding the maximum dose does not increase efficacy.

Official instructions emphasize that the medication must be applied only to a dry scalp, and hands must be washed immediately following the procedure. Furthermore, this treatment is designed for continuous and sustained use. If the regimen is discontinued, any hair regrowth that occurred is generally lost within a few months. For this reason, a minimum of four months of uninterrupted use is necessary before a patient can assess the effect.

Regarding specific populations, the treatment is not for use in individuals under 18 years of age and is generally not recommended for adults over 65. If an application is missed, the user should not double the subsequent dose to catch up.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hairex

Evidence for Use in Hereditary Pattern Hair Loss (Androgenetic Alopecia)

The research base for Hairex, whose active ingredient is Minoxidil, includes primary data from Randomized Controlled Trials (RCTs). These pivotal studies were designed to evaluate Hairex in subjects with hereditary pattern hair loss (androgenetic alopecia) in adults. In these controlled settings, researchers examined how symptoms evolved in the observed populations by observing subjects using Hairex against those using an inactive liquid or foam (a placebo) over defined time intervals. The evidence contributes to the broader evidence landscape by helping to contextualize what has been observed so far in standardized clinical settings.

Overview of Study Designs and Measured Outcomes

The research foundation for Hairex included multiple large RCTs and subsequent Systematic Reviews that combine data from these trials. Research was conducted during periods of increased symptom activity—visible hair thinning—and studies explored short-term symptom changes. The primary focus of researchers was on objective measurements, such as the change in non-vellus (terminal) hair count, in a small, defined area of the scalp.

In addition to hair counting, studies monitored outcomes capturing phases of heightened symptom activity through Investigator Global Assessments, where expert reviewers assessed standardized photographs to record patterns of hair coverage. Researchers also applied studies examining patient-reported experiences, where subjects used questionnaires to describe their perceived change or discomfort related to the thinning over the observation periods.

What Is Still Uncertain About Hairex Research

While Hairex has been extensively studied, a key limitation is that follow-up durations were limited in many pivotal trials, meaning evidence for outcomes across many years of use is not fully established. There is limited information for long-term outcomes regarding the maintenance of the patterns observed beyond one year of continuous use.

Furthermore, research was primarily focused on measuring changes in the vertex (crown) area of the scalp. Comparative evidence is lacking for how reliably the observed patterns of change occur on other parts of the scalp, such as the front hairline. The available research provides context but not individual predictions, as data show patterns related to considerable variability in individual outcomes.

Key Studies & References

  1. Minoxidil: National Library of Medicine (NIH) Bookshelf
  2. Minoxidil Topical Solution/Foam: DailyMed (National Institutes of Health)
  3. Androgenetic Alopecia (Hair Loss) Treatment: NHS Guidance

Frequently Asked Questions (FAQ)

Common questions about Hairex (FAQ)

Q: Are the reported side effects of Hairex common or rare?

Official regulatory information classifies reported side effects into standard frequency groups. Some effects, such as headache, are described as very common. Other effects, including local skin irritation and unwanted non-scalp hair growth (hypertrichosis), are described as common. Less frequent effects, like dizziness or changes in hair texture, are classified as uncommon or rare.

Q: Is Hairex suitable for use by women?

Regulatory documents indicate Hairex is approved for use in both adult men and women experiencing hereditary pattern hair loss. However, the official safety documentation states that the higher 5% concentration is generally not recommended for women due to the increased reported risk of unwanted non-scalp hair growth.

Q: How quickly does Hairex leave the body after stopping use?

Clinical studies on how the body processes the medicine indicate that only a small amount is absorbed through the skin and enters the bloodstream. This absorbed amount is primarily removed from the body through the kidneys and is largely eliminated within a few days (e.g., within four days for topical use). Regulatory information observes that if the regimen is discontinued, any hair regrowth that occurred is generally lost within a few months.

Q: What is the main difference between how Hairex works and how other drugs work?

Official drug information describes Hairex as acting with a dual mechanism within the scalp's hair follicles. This mechanism involves both inhibiting the Type II 5-alpha reductase enzyme and acting as a competitive antagonist at the androgen receptors. This combined action is described as contributing to the modulation of the hair growth cycle.

Q: Can Hairex be crushed or split, according to official guidelines?

Hairex is administered exclusively as a topical solution or topical foam applied directly to the scalp. Official use conditions only describe application in the prescribed liquid or foam measurements. The product is not in a tablet form and is therefore not intended to be manipulated by crushing or splitting.

Q: Is it normal if the color of Hairex tablets seems slightly different sometimes?

Hairex is provided as a topical solution or foam, not a tablet. However, official safety documentation notes that some people have reported changes in hair color and/or texture as an uncommon or rare experience linked to using the product.

Q: Can Hairex cause weight changes?

Regulatory documents list weight increase as a common side effect. Sudden, unexplained weight gain is cited in official documentation as a serious adverse reaction.

Q: Are there different versions or strengths of Hairex available?

Yes. According to official product descriptions, Hairex is offered in two principal dosage forms: a topical solution in 2% and 5% concentrations, and a topical foam available in a 5% concentration.

Q: Is Hairex safe to take with common vitamins or supplements?

Official regulatory information focuses on interactions with other medicinal products and agents that affect systemic absorption, but does not provide specific guidance on general interactions with common vitamins or supplements. Questions regarding the use of Hairex with specific vitamins or supplements are typically discussed with a healthcare professional.

Q: How long does it usually take to see or feel any effect from Hairex?

Clinical studies indicate that visible effects, such as initial regrowth, usually require consistent use for at least two to four months. Official information notes that maximal results are often reported after 12 months of continuous application.

Q: What happens if I forget to take a dose of Hairex?

Official instructions state that if a dose is missed, the user should not attempt to apply the double dose to catch up. The patient should simply continue with the next scheduled application at the regular time.

Q: Are there any specific activities I should avoid while on Hairex?

Official instructions specify that the medicine must not be used 24 hours before and after cosmetic procedures like hair coloring or permanents. Additionally, hands must be washed immediately following the application procedure, and the product must only be applied to a dry scalp.

Q: Can Hairex be used by people who are elderly?

Hairex is generally not recommended for adults over 65 years of age. Regulatory agencies state that the safety and effectiveness of the medicine have not been established in this specific age population.

Q: Is Hairex safe for people with kidney issues?

Official prescribing information does not list kidney issues as a direct contraindication for topical Hairex use. However, because the minimal amount of medicine absorbed into the body is primarily removed by the kidneys, patients with pre-existing renal issues often discuss the use of any medicine with their healthcare professional.

Q: Is there a generic version of Hairex available?

Yes. The active ingredient in Hairex, which is minoxidil, is widely available as an approved generic medication.

Q: Why do some people experience initial side effects with Hairex?

Regulatory information notes that a temporary increase in hair shedding may be observed during the initial phase of treatment. This is described as a transitional effect of the medicine's activity on the hair follicle growth cycle as it attempts to reset the growth cycle.

Q: What does the research say about the effectiveness of Hairex over one year?

The research foundation includes data from studies that observed subjects over 12 months, where maximal effectiveness was often reported. However, official information notes that the follow-up durations were limited in many pivotal trials, meaning evidence for outcomes across many years of use is not fully established.

Q: Do studies suggest Hairex has a risk of dependence?

Hairex is not classified as a controlled substance by regulatory bodies, which means it is not a drug with an official risk for abuse or addiction. Official information does note that continuous use is necessary, and any hair regrowth is generally lost if the regimen is stopped.

Q: Is there a public registry for reporting side effects experienced with Hairex?

Yes. Regulatory bodies like the FDA and others maintain a system where patients and healthcare professionals can formally report adverse events and side effects experienced with medicines like Hairex. This system is intended for the ongoing collection of safety data.

Q: Are there any known drug-drug interactions that are considered minor for Hairex?

Official drug documentation lists specific drug-drug interactions that have been studied, such as with certain topical agents and blood pressure medications. However, the prescribing information generally does not categorize these interactions using the terms 'minor' or 'major' but rather provides a list of cautions and restrictions.

How should Hairex be stored and disposed of?

The storage and disposal of Hairex (Minoxidil) must adhere strictly to the conditions set by regulatory documents to maintain stability and mitigate safety risks.

Requirement Official Regulatory Condition
Storage Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F). Do not refrigerate or freeze.
Protection Keep tightly closed, in a clean, dry place, and protect from light and moisture.
Handling Risk The product is flammable; store away from fire, flame, and heat. The foam container must not be exposed to temperatures above 49 C (120 F) or incinerated.
Child Safety Due to the risk of serious harm from accidental ingestion, keep Hairex out of the sight and reach of children.
Disposal Dispose of unused or expired product according to local pharmaceutical waste regulations or authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hairex found in:

A-Z Index: